EIPM’s 2018 Precision Medicine Symposium
November 21, 2018
The Englander Institute for Precision Medicine’s (EIPM) Symposium fueled innovation and collaboration, bringing together nearly 200 faculty, students, and research staff last Thursday, November 15th. The inaugural event, “Innovations and Emerging Opportunities in Personalized Medicine,” featured speakers across areas of expertise from Weill Cornell Medicine, Cornell University, Cornell Tech, and NewYork-Presbyterian Queens. The full day of presentations covered topics of Novel Therapeutics, Technological Advancements, Drug Target Discovery, and Big Data Integration.
New Pathway Created to Reduce Skin Cancer Risk
November 6, 2018
New research published today in Science Signaling on mechanisms that control skin pigmentation reveal new pathways that could increase the pigmentation of skin and reduce the risk of skin cancer, the most common form of cancer in the United States.
A person’s skin color is determined by the amount and type of melanin in their cells. The production of melanin is influenced by the pH of melanosomes, which is more acidic in lighter skinned people.
Studying Obesity and Breast Cancer Risk
October 29, 2018
Kristy A. Brown, Ph.D., is Assistant Professor of Biochemistry in Medicine at Weill Cornell Medicine. Her work aims to determine how adipose tissue can impact cancer cells, as well as the normal mammary gland, to explain why obese women are more likely to develop breast cancer and die from the disease.
We hope you enjoy learning more about Dr. Brown’s work.
Please tell us about your background and provide an overview of your work.
A Conversation with EIPM's Rohit Chandwani, M.D.
October 26, 2018
A surgeon-scientist, Dr. Chandwani is also Principal Investigator of the Laboratory of Cancer Epigenetics at Weill Cornell Medical College, where he studies the epigenetic dysregulation of pancreatic and liver cancer.
We hope you enjoy learning more about Dr. Chandwani’s work.
Please provide a brief overview of your background and work.
Next-Gen Sequencing in Precision Medicine
October 23, 2018
At the Englander Institute for Precision Medicine (EIPM), we use genomic information to help provide the right treatment to the right patient at the right time. This information is often generated for oncology patients using Next Generation Sequencing (NGS) to quickly and accurately sequence many genes at once.
Dr. Peter Martin, Chief of the Lymphoma Program
October 16, 2018
Earlier this year WCM was selected by the Leukemia and Lymphoma Society as the only medical institution in New York and one of the two sites nationwide to receive a highly competitive grant to improve therapies for mantle cell lymphoma (MCL) patients.
EIPM and ICB Team Translates AI Benefits to In-Vitro Fertilization
August 24, 2018
In addition to advancing cancer research, a team of EIPM and Institute for Computational Biomedicine (ICB) scientists have successfully applied AI to improve embryology and in-vitro fertilization (IVF).
2018 EIPM Summer Internship Highlights
August 20, 2018
With genomic education at the forefront of Weill Cornell Medicine’s mission to care, discover and teach, the Englander Institute for Precision Medicine (EIPM) invited gifted high school and college students to join our multidisciplinary team this summer as part of the inaugural 2018 EIPM Internship Program. While students came from diverse backgrounds, geographic locations, age ranges and skill sets, they left with a shared understanding and appreciation for the critically important role of technology and precision medicine in patient care.
Patient Derived Prostate Cancer Organoids to Advance Precision Medicine
June 28, 2018
A small amount of tumor cells taken from a patient are embedded in an extracellular matrix and grown in the laboratory. As the cells develop in vitro, they form three-dimensional structures that mimic the patient’s disease. These structures, called tumor organoids, are at the forefront of cancer research – they allow researchers to test new drugs and investigate new treatments with a personalized, targeted approach.
Spotlight on Dr. Jan Krumsiek
May 8, 2018
Welcome, Dr. Jan Krumsiek, Assistant Professor of Physiology and Biophysics in the Department of Physiology and Biophysics, and the newest member of the Englander Institute for Precision Medicine. Previously a visiting fellow in the Leandro Cerchietti lab, Dr. Krumsiek answered a few quick questions to elaborate on his experience and interests.
Please provide a brief overview of your work before Weill Cornell Medicine.